 And I'm here with Vi Cardio, I've got Steve and David. So guys, I really wanted to start by asking, perhaps with you, Steve, so what's your background? What brings you to this world of blood pressure monitoring? So my background is I'm an engineer and became a lawyer. I had a 22 year practice with the largest intellectual property law firm in the world, Fish and Richardson. And during the course of my work, I came to be introduced to the founders of Vi Cardio and helped build a patent portfolio around that technology. As the technology was coming toward its market launch, which will happen in 2019, I decided to myself I wanted to take a pretty radical career jump and join the Vi Cardio and its parent company, the Terilian Laser Technology team on the inside. And that's what I did one year ago today. And I'm happy to be part of the team. The conference talks are now available. OK, I think we'll just wait and maybe crop through this bit of the audio. Just so we lose the announcement, but that was great. It's a lovely pass at the registration. That is the conference talks are now available. Excellent. Excellent, so how about you, David? You come from perhaps a different background. What brings you to Vi Cardio? Yeah, my background is as a general practitioner, and I've been in medical and legal IT for nearly 20 years now. I was introduced to Vi Cardio first and Terilian Laser Technologies as an investor, but soon really realized the absolute importance of this technology for medicine worldwide and so have become more involved in looking at the strategy for bringing Vi Cardio to market and the IT background and support for that product. Well, perhaps you can expand on that. So you mentioned its importance within medicine worldwide. Can you talk a bit more to what the product is really doing within that ecosystem? Yeah, I mean, cuffless blood pressure monitoring has been a 50-year journey of somebody trying to find a solution to the traditional oscilometric cuff. That is an inaccurate technology. It's painful, it's disliked, it's cumbersome. And the idea of having a wearable, beat-to-beat blood pressure product which doesn't compress the artery and can take multiple readings throughout the day and even night has really been something which the world's been striving for. And when I came across Terilian Laser Technologies and the Vi Cardio product, I saw that this technology works and it can absolutely revolutionize the world of blood pressure monitoring. Sure, so Steve, perhaps we'll move to you now. So within the sort of commercial side of this, when we're talking about the impact that a beat-to-beat blood pressure monitor can have within this space, what's your target for this device when you're looking in terms of commercialization and development? So it's a broad applicability technology. David alluded to with Vi Cardio, it is direct to consumer with a focus toward hypertensives who are trying to manage their blood pressure on a day-to-day basis. But it goes way beyond that. It goes into the important hospital community to have a technology that can get blood pressure through the entire process, through intake, through a critical care procedure to, and very importantly, in the recovery ward to make recovery less painful than having your arms squeezed every 15 minutes. So and then you can imagine integrating our technology into the mass health and fitness wearables. So there's a broad range of market segments that we're interested in. And we're interested in making partnerships to pursue all of those. Excellent, so what about the near term? What are you looking to now? What's happening with Vi Cardio at the moment? What about the commercialization in the near future? I mean, perhaps David. Yeah, so it's a very exciting time. We've recently completed, successfully, our clinical trial at Barts, where we've compared Vi Cardio and the Torilian sensor to the gold standard, the arterial line. We're hopefully days away from having the independent statisticians report on that trial. And following that, we'll be applying immediately for our C mark and then FDA approval in sort of quarter two, 2019. And at the same time, we are in our final prototypes, which have come on a huge amount since we last spoke in Berlin. And we're building up the app. And we now got, today, we've been demonstrating the app on iOS, which has been really good to see. And so, yeah, the e-commerce backend and bringing that product to market as soon as we get the C marking is our priority. Excellent. And I see, Steve, you're wearing a new version of the product here, is this? This is Vi Cardio. And this is the design, as it will be launched to the market. It communicates with your smartphone. So you'll get the waveform of blood pressure, the continuous waveform of blood pressure on your smartphone, plus blood pressure measurements for each bead of your heart. Fantastic. Well, it's really great to hear updates from you guys, like hearing how much you've come since we, I guess, last spoke at the ID TechEx show in Berlin back in April this year, seeing the prototype, hearing the progress with the trial. It's really great to see for a really, really important application. So thank you for being here and thank you for this interview and all the best with the future in terms of getting those C mark FDA approval and then commercializing this product. OK, thank you. Thanks.